Cibinqo

(abrocitinib) Pfizer

Composition:

Each film-coated tablet contains 50mg or 100 mg or 200 mg of abrocitinib.

Indications:

Cibinqo is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable